Labelling of peptides with <Superscript>99m</Superscript>Tc complexes through the modified C-terminal group

Easy and efficient way to modify of the C-terminus of the peptide using amino acid lysine has been proposed and experimentally verified. The synthesis yield was high (≥85%) and it was found that reactions can be carried out even with microgram amounts of the peptide. Using Fmoc-alanine (as the peptide model) with modified C-terminus the procedure of peptide labelling with monovalent and trivalent ^99mTc complexes has been elaborated.     

Synthesis, radiochemistry and stability of the conjugates of technetium-99m complexes with Substance P

Two types of technetium-99m complexes: (i) with the Hynic ligand linked to Substance P(1–11) and (ii) of the type ‘4 + 1’ consisting of tetradentate tripodal chelator tris(2-mercaptoethyl)-amine and monodentate isocyanide ligand previously coupled with Substance P(1–11), have been prepared on the n.c.a. scale. The obtained conjugates exhibit different lipophilicity and high stability in neutral aqueous solutions, even in the presence of excess concentration of histidine/cysteine competitive standard ligands. The conjugate (^99mTc(NS₃)(CN))₂–SP containing two technetium-99m species in the molecule may be expected to be an extremely good diagnostic radiopharmaceutical.     

Structural features of tricarbonyl(N-methyl-2-pyridinecarboxyamide)chloro-rhenium(I)-potential precursor of radiopharmaceuticals

Structural characteristics of the novel [fac-Re(CO)₃L]Cl complex, where L denotes the N-methyl-2-pyridinecarboxyamide, are presented. Molecular structure of the complex has been established by means of X-ray single crystal diffraction and compared with quantum mechanical calculations. It has been shown that pyridinethioamide is softer base than pyridineamide. As a result of different Re^I–S and Re^I–O bond covalent shortenings (reflecting their diverse ionic/covalent character ratio) difference of the bond lengths decreases from a theoretical value of 0.45 Å to the value of 0.28 Å.     

Common Shortcomings in Study on Radiopharmaceutical Design Research: A Case Study of 99mTc-Labelled Methotrexate

The aim of the work carried out was to draw attention to shortcomings that often appear at the stage of designing new radiopharmaceuticals. Based on a case study of ^99mTc-labelled methotrexate, this article describes frequent mistakes or misconceptions present not only in the referenced studies, but also in numerous radiopharmaceutical studies. The recommendations provided in this article highlight fundamental aspects of the credibility of radiopharmaceutical scientific research leading to the reliable results.     

Technetium(I) tricarbonyl complexes: potential precursors of the radiopharmaceuticals. Part II: phenethylbiguanide (phenformin)

The radiosynthesis of [^99mTc]-phenformin ([^99mTc]-1-phenethylbiguanide) complex and its suitability as precursor of the radiopharmaceuticals for the tumor imaging was assessed. Radiochemical purity of the [^99mTc]-complex was determined using radio-TLC and was studied by the HPLC with radiochemical detection, while its stability in challenge experiments. The results show, that due to the sufficient stability and lipophilicity of the complex, it fulfills our expectations for promising radiopharmaceutical precursor not only for the diagnostic agent, but also for the drug suitable for the oncological Auger electron therapy.     

Technetium(I) tricarbonyl complexed with the N-heterocyclic aldehyde thiosemicarbazones: potential precursors of the radiopharmaceuticals

Technetium(I) tricarbonyl complexes may form with the pyridine aldehyde thiosemicarbazones (TSCs), in which chelating ligand is bound tri- or bidentately. Intend of the presented work was to check, if labeling the N-heterocyclic TSCs with tricarbonyl [^99mTc]-technetium(I) may lead to formation of the complexes suitable for the radiopharmaceutical purposes. Syntheses of the complexes were provided in the conditions analogous to those performed in the nuclear medicine laboratories. Main physicochemical properties of the complexes important in the medicinal chemistry were studied. Relevant results of the numerical calculations remain in fair agreement with these properties.     

Replicates Number for Drug Stability Testing during Bioanalytical Method Validation—An Experimental and Retrospective Approach

Background: The stability of a drug or metabolites in biological matrices is an essential part of bioanalytical method validation, but the justification of its sample size (replicates number) is insufficient. The international guidelines differ in recommended sample size to study stability from no recommendation to at least three quality control samples. Testing of three samples may lead to results biased by a single outlier. We aimed to evaluate the optimal sample size for stability testing based on 90% confidence intervals. Methods: We conducted the experimental, retrospective (264 confidence intervals for the stability of nine drugs during regulatory bioanalytical method validation), and theoretical (mathematical) studies. We generated experimental stability data (40 confidence intervals) for two analytes—tramadol and its major metabolite (O-desmethyl-tramadol)—in two concentrations, two storage conditions, and in five sample sizes (n = 3, 4, 5, 6, or 8). Results: The 90% confidence intervals were wider for low than for high concentrations in 18 out of 20 cases. For n = 5 each stability test passed, and the width of the confidence intervals was below 20%. The results of the retrospective study and the theoretical analysis supported the experimental observations that five or six repetitions ensure that confidence intervals fall within 85–115% acceptance criteria. Conclusions: Five repetitions are optimal for the assessment of analyte stability. We hope to initiate discussion and stimulate further research on the sample size for stability testing.     

Tricarbonyltechnetium(I) and tricarbonylrhenium(I) complexed with N-methyl-2-pyridinecarboxyamide as potential radiopharmaceuticals: a computational study

The electronic and thermodynamic properties of the ‘2 + 1’ tricarbonyltechnetium(I) and -rhenium(I) mixed ligand complexes with N-methylpyridine-2-carboxyamide (MPCA) as a bidentate ligand and chloride, water, or tert-butyl-3-isocyanopropanoate (BCP), were investigated within the framework of Density Functional Theory. The atomic charges of all complexes, polarization of the CO groups, as well as the effect of transfer of π-electron density between the ligands through the metal were calculated and compared. The free energies of the reaction of formation of the isocyanide complexes in aqueous solution were calculated based on calculated total free energies in aqueous solution of the products and the substrates. The dissociation energies of the complexes were also determined in order to rationalize the experimentally observed higher resistance of the rhenium compared to the technetium complexes in the challenge experiments with the standard sulfur-containing amino acids.     

Synthesis,physicochemical and in vitro biological evaluation of 99mTc-cefepime radioconjugates,and development of DTPA-cefepime single vial kit formulation for labelling with technetium-99m

Journal of Radioanalytical and Nuclear Chemistry - In the present work the synthesis, physicochemical properties and biological evaluation of cefepime (CFM) labelled with technetium-99m were...